Mirati Therapeutics Inc. (MRTX)
NASDAQ: MRTX
· Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM
Mirati Therapeutics Revenue
Mirati Therapeutics reported an annual revenue of $12.44M, reflecting a -82.75% growth. For the quarter ending September 30, 2023, Mirati Therapeutics generated $16.4M in revenue.
Revenue (ttm)
12.44M
Revenue Growth
-82.75%
Price / Sales Ratio
204.88
Revenue / Employee
21.19K
Employees
587
Market Cap
4.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 12.44M | -82.75% |
| Dec 31, 2021 | 72.09M | +438.08% |
| Dec 31, 2020 | 13.4M | +301.74% |
| Dec 31, 2019 | 3.33M | -74.20% |
| Dec 31, 2018 | 12.93M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | -100.00% |
| Dec 31, 2012 | 2.01K | -99.93% |
| Dec 31, 2011 | 3.03M | +26.75% |
| Dec 31, 2010 | 2.39M | -17.16% |
| Dec 31, 2009 | 2.88M | -88.10% |
| Dec 31, 2008 | 24.24M | +54.83% |
| Dec 31, 2007 | 15.65M | +13.85% |
| Dec 31, 2006 | 13.75M | +138.78% |
| Dec 31, 2005 | 5.76M | -25.05% |
| Dec 31, 2004 | 7.68M | -0.38% |
| Dec 31, 2003 | 7.71M | n/a |